Product Datasheet
ERK1 Antibody
Catalog Number: 48504
Technical:tech@swbio.com
Information:info@swbio.com
Description
- Swiss-Prot No.:
- Swiss-Prot#:P27361
- Form of Antibody:
- 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
- appl_detail:
- WB: 1:500-1:1,000
IHC: 1:200
ICC: 1:200
- other_names:
- ERK 1 antibody
ERK antibody
ERK-1 antibody
ERK1 antibody
ERT 2 antibody
ERT2 antibody
Extracellular Signal Regulated Kinase 1 antibody
Extracellular signal related kinase 1 antibody
Extracellular sig
- Purification:
- Peptide affinity purified
- Applications:
- WB, ICC, IHC
- Background:
- Mitogen-activated protein kinases (MAPKs) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs, such as cell proliferation, differentiation, motility, and death. The p44/42 MAPK (Erk1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines , and research investigators consider it an important target in the diagnosis and treatment of cancer . Upon stimulation, a sequential three-part protein kinase cascade is initiated, consisting of a MAP kinase kinase kinase (MAPKKK or MAP3K), a MAP kinase kinase (MAPKK or MAP2K), and a MAP kinase (MAPK). Multiple p44/42 MAP3Ks have been identified, including members of the Raf family, as well as Mos and Tpl2/COT. MEK1 and MEK2 are the primary MAPKKs in this pathway.
© Signalway Biotechnology All Rights Reserved.